NetworkNewsWire Announces Publication on Recreational Marijuana and How Canada's Producers are Rising to Meet Demand

NEW YORK, NY--(Marketwired - Nov 21, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring ABcann Global Corp. (OTCQB: ABCCF) (TSX VENTURE: ABCN), a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis and one of the earliest licensed Canadian medical marijuana producers.

The publication, titled, "Coming Cannabis Recreational Demand in Canada Triggers Massive Investment," discusses the operations of several of Canada's leading licensed cannabis producers, and how they are gearing up for an anticipated increase in product demand.

To view the full publication, visit: https://www.networknewswire.com/coming-cannabis-recreational-demand-canada-triggers-massive-investment/

"The Canadian government's commitment to legalize recreational cannabis in July 2018 is touted as an opportunity for investors to profit from the ongoing green blitz. Gearing up for the anticipated spike in consumer demand, cannabis-related businesses are lining up steady sources of supply from the country's licensed producers (LPs). The alcohol and tobacco industries are also preparing to get their hands on the plush opportunities of legalized recreational cannabis. One of Canada's earliest licensed cannabis producers, ABcann Global Corp. (OTCQB: ABCCF) (TSX VENTURE: ABCN) (ABCCF Profile), is well-positioned to capitalize on the market's expansion with its computer-controlled growing platform that helps it produce more than 250 grams of cannabis per square foot each year, placing it among the highest yields within the Canadian sector.

"In order to take advantage of Canada's projected $9 billion cannabis market, companies like ABcann must keep an eye on the future while taking care of the present. The company's announcement last month that Paul Lucas will be its new independent chairman following founder Ken Clement's decision to step down shows a keen eye for continuity of leadership and historical knowledge of the industry (http://nnw.fm/n3fU0). Lucas, former president and CEO of GlaxoSmithKline Canada, brings decades of pharmaceutical industry experience to his new role at ABcann Global. That kind of global experience will serve the company well as it looks to expand its footprint in the legal cannabis industry. ABcann's vision includes becoming a global presence in the legalized marijuana markets of Canada, Germany, all of Western Europe and South America (http://nnw.fm/Z60nx)."